Suppr超能文献

肿瘤芽生在胆管癌中的预后意义。

Prognostic significance of tumor budding in biliary tract cancer.

作者信息

Regmi Parbatraj, Paudyal Aliza, Paudyal Pranita, Hu Hai-Jie, Liu Fei, Ma Wen-Jie, Jin Yan-Wen, Li Fu-Yu

机构信息

Department of Biliary Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.

Department of Dermatology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.

出版信息

Eur J Surg Oncol. 2022 Jan;48(1):160-168. doi: 10.1016/j.ejso.2021.08.008. Epub 2021 Aug 13.

Abstract

BACKGROUND

Tumor budding is a significant prognostic indicator for poor survival of several solid tumors. However, due to the lack of a standard scoring system, its clinical application for biliary tract cancer (BTC) is limited.

OBJECTIVE

To identify the prognostic significance of tumor budding in BTC.

RESULTS

Tumor budding was associated with poor histologic differentiation, lymphovascular invasion, perineural invasion, lymph node metastasis, positive surgical margin, etc. Tumor budding was a predictor of poor OS in univariate (HR: 4.36; 95% CI 3.15 to 6.02; P < 0.001) and multivariate (HR: 2.95; 95% CI 2.28 to 3.80; P < 0.001) analysis. Similarly, it was also a predictor of poor DFS in univariate (HR: 3.26; 95% CI 2.12 to 4.99; P < 0.001) and multivariate (HR: 3.21; 95% CI 1.90 to 5.40; P < 0.001) analysis. In addition, tumor budding was also associated with advanced T-stage, poor histologic differentiation, lymph node metastasis, positive resection margin, lymphatic invasion, vascular invasion, and perineural invasion.

CONCLUSION

Results of our study have shown that tumor budding is a strong predictor of poor survival for BTC. The clinical utility of tumor budding as a prognostic marker for BTC should be considered after developing a standard international consensus based on the current evidence.

摘要

背景

肿瘤芽生是多种实体瘤预后不良的重要指标。然而,由于缺乏标准的评分系统,其在胆管癌(BTC)中的临床应用受到限制。

目的

确定肿瘤芽生在BTC中的预后意义。

结果

肿瘤芽生与组织学分化差、淋巴管侵犯、神经周围侵犯、淋巴结转移、手术切缘阳性等相关。在单因素分析(HR:4.36;95%CI 3.15至6.02;P<0.001)和多因素分析(HR:2.95;95%CI 2.28至3.80;P<0.001)中,肿瘤芽生是总生存期差的预测指标。同样,在单因素分析(HR:3.26;95%CI 2.12至4.99;P<0.001)和多因素分析(HR:3.21;95%CI 1.90至5.40;P<0.001)中,它也是无病生存期差的预测指标。此外,肿瘤芽生还与T分期晚、组织学分化差、淋巴结转移、切除边缘阳性、淋巴管侵犯、血管侵犯和神经周围侵犯相关。

结论

我们的研究结果表明,肿瘤芽生是BTC患者生存预后不良的有力预测指标。应在现有证据基础上形成国际标准共识后,考虑将肿瘤芽生作为BTC预后标志物的临床应用价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验